The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...

SARS-CoV-2 infection was associated with more rapid coronary plaque progression and significantly increased risk for adverse ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.

Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...

Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...

This page requires JavaScript to be enabled to properly display data shown within components like charts, tables, etc.. Circulation of respiratory viruses is normally ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

People who have had multiple bouts of COVID-19 or had it severely, and those who were unvaccinated when first infected, had an increased risk of developing long COVID, according to a new study by ...

However, its use in patients receiving immunosuppressants, such as tacrolimus, is limited by significant drug-drug interactions arising from the ritonavir component of the combination (1). VV116 is a ...

Property News: This vendor is selling their backyard including a swimming pool and hill-hoist but you don't get the house. © 2025 Nine Entertainment Co.

All suppliers new to UB are required to submit a completed tax ID form to Procurement Services as confirmation of their business identity. This information is used to build supplier profiles in the ...